The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of bone marrow involvement in patients with peripheral T-cell lymphoma undergoing autologous stem cell transplant.
 
Robert Stuver
No Relationships to Disclose
 
Anita Mazloom
No Relationships to Disclose
 
Nivetha Ganesan
No Relationships to Disclose
 
Steven M. Horwitz
Consulting or Advisory Role - Acrotech Biopharma; ADC Therapeutics; Astex Pharmaceuticals; C4 Therapeutics; Celgene; Janssen Oncology; Kura Oncology; Kyowa Hakko Kirin; Millennium; Myeloid Therapeutics; Ono Pharmaceutical; Seagen; Secura Bio; Shoreline Biosciences; Takeda; Trillium Therapeutics; Tubulis GmbH; Verastem; Vividion Therapeutics
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Aileron Therapeutics (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Forty Seven (Inst); Kyowa Hakko Kirin (Inst); Seagen (Inst); Secura Bio (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Verastem (Inst)
 
Alison J. Moskowitz
Honoraria - Seagen
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb; Imbrium Therapeutics; Janpix; Kyowa Kirin International; Merck; miRagen; Seagen; Takeda
Research Funding - ADC Therapeutics (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); miRagen (Inst); Seagen (Inst)